Z-ligustilide attenuates lipopolysaccharide-induced proinflammatory response via inhibiting NF-κB pathway in primary rat microglia

Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders

(2010) R. Lee Mosley et al.   EXPERIMENTAL NEUROLOGY

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease

(2009) Qingguang Jiang et al.   CNS DRUGS

Inflammatory mechanisms in ischemic stroke: therapeutic approaches

(2009) Shaheen E Lakhan et al.   Journal of Translational Medicine

Protective effect of Z-ligustilide against amyloid β-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains

(2009) Xi Kuang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Non-Steroidal Anti-Inflammatory Drugs as Anti-Amyloidogenic Compounds

(2008) Mie Hirohata et al.   CURRENT PHARMACEUTICAL DESIGN

Microglial Dysfunction and Defective  -Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

(2008) S. E. Hickman et al.   JOURNAL OF NEUROSCIENCE

Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats

(2007) X KUANG et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR